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Introduction 
Chronic pain is experienced when, subsequent to the subacute phase of healing, pain 
persists beyond the expected healing time frame, leading to poor outcomes. Existing studies 
have investigated predictors of poor outcomes associated with musculoskeletal pain 
including disability (Sterling et al, 2006; Walton et al., 2011), and failure to return to work 
(see Iles et al., 2008, 2009 for reviews). However, there remains little consensus, probably 
due to the heterogeneity of outcomes studied and, moreover, the heterogeneity of pain 
mechanisms. Hence, the transition from acute musculoskeletal pain to chronic pain is 
currently difficult to predict.  
 
Common to a significant proportion of chronic musculoskeletal pain populations is the 
phenomenon of sensitisation of the central nervous system pain pathways, i.e. altered 
central pain modulation. Altered central pain modulation manifests as a predominantly non-
nociceptive, non-neuropathic pain mechanism (Smart et al., 2012; Nijs et al., 2014) and is 
defined as a dysregulation of the central nervous system causing neuronal hyper-excitability, 
characterised by generalised hypersensitivity of the somatosensory system to both noxious 
and non-noxious stimuli (Nijs et al., 2010; Smart et al., 2012). Altered central pain 
modulation involves impaired modulatory mechanisms within the central nervous system 
whereby nociceptive pathways are less inhibited and nociceptive facilitatory pathways 
enhanced, resulting in augmentation of nociceptive transmission (Baert et al., 2015).  
Poor outcomes such as disability are not necessarily an indication of altered central pain 
modulation per se, despite being commonly associated with each other (Sterling et al, 2003; 
Ferrari, 2010). Disability may be the result of psychological factors that may not be 
predominantly a result of altered central pain modulation, such as fear avoidance (Vlaeyen 
and Linton, 2000). Similarly, poor outcomes such as chronic pain may or may not be an 
indication of altered central pain modulation, depending on the predominant pain 
mechanism. It is proposed that the phenomenon of altered central pain modulation should 
be investigated specifically in the aetiology of poor outcomes. 
 
A strong clinical predictor of altered central pain modulation is "disproportionate, non-
mechanical, unpredictable pattern of pain provocation in response to multiple/non-specific 
aggravating/easing factors" (Smart et al., 2012; p.342). Altered central pain modulation is 
associated with many non-specific chronic musculoskeletal pain conditions and the aetiology 
is poorly understood. It is considered by some that altered central pain modulation is a 
disease in itself rather than a disease of the particular presenting musculoskeletal condition 
(Mogil, 2012). From a clinical perspective, identifying predictors of altered central pain 
modulation may help to sub-classify “at-risk” patients at baseline after acute musculoskeletal 
pain onset. Appropriate management could then be prioritised accordingly to minimise the 
risk of altered central pain modulation and poor outcomes. 
 
Therefore, the aim of the current study is to firstly, identify predictors of altered central pain 
modulation in adults with general musculoskeletal pain conditions and secondly, if data 
allow, determine predictors for altered central pain modulation in patients with non-specific 
low back pain. The scope of the current review follows the type of model intended to inform 
clinicians’ therapeutic decision making, in accordance with Moons et al., (2014).  It intends to 
focus on prognostic studies designed to predict a future health outcome (altered central pain 
modulation) as opposed to diagnostic predictor models or models designed to identify 
suspected existing disease (Moons et al., 2014). 
  
Methods 
The review protocol was registered prior to commencement of the search with PROSPERO, 
protocol no.: PROSPERO 2015:CRD42015032394. The methods used in the current study 
follow the guidelines published in the PRISMA Statement for systematic reviews (Moher et 
al., 2009). This is supplemented by methodological guidelines specific to systematic reviews 
of prognostic studies by Dretzke et al., (2014) and Moons et al., (2014). 
 
 
  
Search strategy 
The following electronic databases were searched from their inception up to March 2016: 
EMBASE (via Ovid), Medline (via Ovid), CINAHL (EBSCO), Scopus, Web of Science (via 
Web of Knowledge) and Google Scholar. Reference lists of the eligible studies were hand 
searched and 31 other researchers in the field were contacted by email by JC in order to 
identify any missed, potentially important studies. 
 
A pilot search was carried out to test preliminary search terms identified from related 
literature. With a view to finding studies detailing prognostic indicators which predict altered 
central pain modulation, the search term “Prognos*” was piloted. This was with the intention 
of capturing terms such as prognosis / prognostic indicators / prognostic factors / poor 
prognosis and was initially focussed on low back pain (LBP) populations. However, it 
became clear that the studies with chronic LBP and prognos* were generally looking at the 
natural course of LBP or the response to management regarding whether or not they would 
return to work. Therefore the pilot search was altered to acute low back pain AND prognos* 
because this would potentially yield prognostic indicators for a poor outcome in acute LBP. 
However, poor outcome in acute LBP can lead to various outcomes such as disability or 
persistent pain, which are not specific to altered central pain modulation. Therefore, specific 
terms for the outcome measures of altered central pain modulation had to be developed, 
with the assistance of examples drawn from other review studies in altered central pain 
modulation (Roussel et al., 2013; Malfliet et al., 2015). 
 
The term predict* was chosen because statistically logistic regression models are used to 
find predictors (Field, 2009). Dretzke et al., (2014) advises the use of both prognosis- and 
predictor-related terms, without filters, so as to minimise loss of relevant studies. 
 
The term “central sensitisation” was also piloted. It became clear that there are two spellings, 
English and American, the latter using “z”, as in “sensitization.” Both spellings had to be 
included. No word filters were applied to the search strategy.  
 
Subsequently, the systematic search was conducted to locate studies relevant to three key 
subject areas of the research question: 1) central sensitisation pain due to altered central 
pain modulation, 2) predictors and 3) musculoskeletal pain known to be associated with 
altered central pain modulation (Yunus, 2008), using the tested search terms. Keywords or 
database specific search terms (e.g. MeSH, subject terms, subject headings, and CINAHL 
headings) or a combination of both were used. The Boolean operators “OR” and “AND” were 
used to combine search terms within and between each of the subject areas. No time limits 
were applied to any of the databases. No filters were used in the search strategies, as 
recommended by Dretzke et al., (2014). Only full text studies reported in English were to be 
included. The systematic search was carried out independently by JC and PG. The search 
terms are detailed in table 1. 
 
  
Table 1. Search terms 
Target	Population:		
	
Musculoskeletal	pain	
(“low	back	pain”	OR	backache	OR	lumbago	OR	“ache,	low	back”	OR	
“Low*	back	pain”	OR	“neck	pain”	OR	“cervical	pain*”	OR	cervicalgia	OR	
cervicodynia	OR	“temporomandibular	pain*”	OR	“widespread	pain*”	
OR	“musculoskeletal	pain”	OR	“shoulder	pain”	OR	whiplash)	
	 And:	
Target	condition:		
	
Central	sensitisation	
pain;	altered	central	
pain	modulation	
	(“Central	pain”	OR	“central	sensitisation”	OR	“central	sensitization”	
OR	“central	sensitivity”	OR	“central	hypersensitivity”	OR	“endogenous	
analgesia”	OR	“descending	nociceptive	inhibition”	OR	“descending	
facilitation”	OR	“nociceptive	facilitation”	OR	“central	pain	
modulation”)	
	 And:	
Methodology:		
	
prospective	predictive	
cohort	studies	using	
regression	analysis	
	
	(inception	OR	prognos*	OR	predict*	OR	prospective	OR	cohort	OR	
longitudinal	OR	“follow-up”	OR	“follow	up	study”	OR	Risk)		
 
 
Eligibility Criteria 
The review included only predictive or prognostic studies where baseline predictive factor 
measurements were taken pre-morbidly or at the acute stage of musculoskeletal pain onset. 
The primary outcome measurements were those that indicate a likelihood of the pain 
mechanism being specific to altered central pain modulation, measured at least 3 months 
after the initial acute pain onset. Longitudinal data were used in logistic regression models of 
analysis to identify predictors of altered central pain modulation. 
 
Although prognostic longitudinal cohort studies using logistic regression models of analysis 
were expected in the search, it was agreed at the outset not to restrict the search to those 
only using logistic regression models of analysis. This decision was made in anticipation of a 
small number of studies eligible for inclusion to avoid unnecessary exclusion. It was 
proposed, a priori, that authors of potentially relevant studies could be contacted for 
permission to re-run their data through a logistic regression analysis if necessary and if 
possible. 
 
Of critical importance to this review was the primary outcomes specific to altered central pain 
modulation. An anticipated potential difficulty was the lack of a single gold standard 
measurement tool for the determination of altered central pain modulation. Quantitative 
sensory testing (QST) is an acceptable measurement procedure for sensory hypersensitivity 
(Shy et al.; 2003), a manifestation of altered central pain modulation. Another acceptable 
measure of altered central pain modulation is the Central Sensitisation Inventory (CSI) 
questionnaire (Mayer et al., 2012) validated in 2013 by Neblett et al., (2013). The CSI gives 
a score that indicates the likelihood of symptoms being attributed to altered central pain 
modulation. More recent clinical guidelines have been available detailing how to clinically 
identify altered central pain modulation (Smart et al., 2012; Nijs et al, 2014). Outcome 
measurements paralleling any of these guidelines were anticipated as being acceptable in 
the search process, especially for studies published before 2012 which did not use QST as 
the primary outcome measure. 
 
Table 2. Eligibility criteria for study screening 
Inclusion Criteria Exclusion criteria 
Prognostic longitudinal studies Non musculoskeletal pain populations 
Participants - Adult (age 18-65) people aged under 18  or over 65;  
Recruited pre-morbidly or at the acute pain 
onset with follow-up at least 3 months after 
pain onset. 
Specific pathologies; post-surgical pain 
studies; 
musculoskeletal pain (known to be 
associated with altered central pain 
modulation) 
rheumatoid arthritis or any other rheumatic, 
neurological, oncological or internal 
disease. 
measuring an outcome of altered central 
pain modulation according to clinical 
guidelines [5] (if described) or using QST 
Functional outcomes not specific to altered 
central pain modulation such as return to 
work or disability-only outcomes. 
	
Study selection: 
Studies were screened according to titles and then by abstracts, based on the inclusion and 
exclusion criteria listed in table 2. All studies were independently screened by two reviewers 
(JC/PG) before collaboration on the screening. In the case of disagreement a third reviewer 
was available for consultation (GY). Discussion between reviewers enabled a consensus to 
be reached regarding the eligibility of the final studies for inclusion. 
 
Risk of bias (quality) assessment:  
At the study level, the QUIPS (Quality in Prognostic Studies; Hayden et al., 2013) risk of bias 
tool for prognostic studies was used to assess the quality of each study. This was tailored to 
the requirements of the review and supplemented by recommendations from the CHARMS 
(Checklist for Critical Appraisal and Data Extraction for Systematic Reviews of Prediction 
Modelling Studies) checklist by Moons et al., (2014). The final seven-part risk of bias check 
list was used to grade each study with an overall score of low, moderate, or high risk of bias, 
according to the QUIPS grading guidelines. The risk of bias grades were taken into 
consideration when evaluating the strength of findings in each predictive study. 
 
Overall quality of evidence and strength of recommendation was determined using the 
Grading of Recommendations, Assessment, Development and Evaluations (GRADE) criteria 
(Guyatt et al., 2008). The final GRADE score incorporated the 4 categories, quality, 
consistency, directness and effect size. Evidence quality was based on the overall GRADE 
scores for each comparison and graded: high (at least 4 points overall), moderate (3 points), 
low (2 points), or very low (1 or less). 
 
 
 
Data extraction (selection and coding) 
JC and PG independently extracted results from the included studies.  
Given the small number of studies and the variation in predictors and outcome measures 
across the selection, statistical pooling of data was not feasible. Instead, findings were 
synthesised qualitatively. 
 
 
Results 
The initial search yield was n=2,368 hits from the databases and n=13 from additional 
sources (Fig 1). After removal of duplicates, n=171 articles were selected from the initial hits. 
Screening of the titles, using the inclusion and exclusion criteria reduced the yield to n=107. 
Further screening by abstract reduced the yield to n=36. N=1 article was excluded as it could 
not be retrieved (Murphy and Cornish, 1984). Further exclusions were made based on non-
English language reporting (n=2), primary outcomes not specific to altered central pain 
modulation (n=22), too short a follow-up time (n=1), subjects being above age 65 (n=1) and 
only associations being calculated (n=1). The total number of full articles selected was n=9. 
Full text articles were screened by JC and PG and there was no disagreement requiring 
consultation with the third reviewer (GY). Based on the research question, the inclusion and 
exclusion criteria and clinical knowledge of altered central pain modulation, it was agreed by 
consensus that the n=9 studies meeting study eligibility were: McBeth et al., (2001), Sterling 
et al., (2003), Harkness et al., (2004), Diatchenko et al., (2005), Gupta et al., (2007), Wynne-
Jones et al., (2006), Ferrari, (2010), Slade et al., (2014) and Markkula et al., (2016). 
One corresponding author was contacted in order to clarify a reporting error – the study 
reported that high tender point counts significantly predict WP but quoted a non-significant p 
value of 0.157 (Gupta et al., 2007). It was confirmed by the author as a typographical error in 
the article and corrected as p=0.042.  
 
 
 
Figure 1. PRISMA flowchart describing the selection of articles. 
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Table 4: Study Demographics 
Study	 Age	(years)	
	
	
Male	/	female	
	
Setting	
McBeth	et	al.	
2001	
Range = 18-64 Male n=608,  
Female n=796. 
Random population sample, UK 
Sterling	et	al.	
2003	
Mean = 36.27(SD+/-
12.69) 
Controls: mean = 40.1 
(SD+/- 13.6 years) 
Male n=24,  
Female n=56,  
 
20 controls 
8 males, 12 females,  
 
Hospital accident and emergency departments, 
primary care practices (medical and physiotherapy) 
and media advertisements 
Harkness	et	
al.	2004	
	
Median = 23 Male Approx. 1/3  12 diverse occupational settings 
Diatchenko	
et	al.	2005	
Range = 18-34 Females n=202 
 
 
Setting not mentioned 
? population study implied 
Wynne-	
Jones	et	al.	
2006	
Median = 41 yrs. [IQR= 
33–50] 
 
Female = 51% 
 
UK based vehicle insurance co. 
Gupta	et	al.		
2007	
25–39 n=66 (28.6%) 
40–49 n=54 (23.4%) 
50–65 n=111 (48%) 
 
Male n=71 (30.7%) 
Female n=160 (69.3%) 
 
Three population-based primary care registers 
covering two socio-demographically mixed suburban 
areas 
Ferrari	2010	
	
Mean = 37.5 (SD+/-13) 
 
Male n=32,  
Female n=37  
 
Single primary care walk-in clinic in Canada 
Slade	et	al.	
2014	
	
Range = 18-44  Not stated OPPERA (Orofacial Pain: Prospective Evaluation and 
Risk Assessment) research clinic USA 
Markkula	et	
al.	2016	
Mean = 27.7 (SD± 7.3) Male = 46.2%  
Female = 53.8% . 
 
Finnish Twin Cohort, Finland 
 
 
  
Table 5: Summary of study characteristialtered central pain modulation 
Study	 Study 
Design 
Condition Inclusion / exclusion 
criteria 
Base-line time 
point 
Predictors  Primary outcome 
measure 
Follow-up   Results as presented in study 
McBeth	et	al.	
2001	
Population 
based 
prospective 
study 
 WP Included if free of WP pre-
morbidly and showed 
evidence of somatisation 
Pre-morbid ACR criteria for WP 
Somatising Q’aires: somatic 
symptoms checklist 
 
Illness Attitudes Scale 
 
General health Questionnaire 
 
Fatigue questionnaire 
All described and valid 
ACR criteria for WP 
 
12 months Illness Behaviour Scale and Somatic Symptom scores most strongly 
predicted new onset chronic WP at 12 months. 
Strong relationships between baseline test scores and subsequent 
risk of chronic WP (odds ratio for the Somatic Symptom Checklist 
3.3; odds ratio for the Illness Behavior subscale of the Illness 
Attitude Scales 9.0). All 95% confidence intervals excluded unity. 
These associations were independent of baseline pain status. 
 
Sterling	et	al.	
2003	
Prospective 
cohort 
Whiplash Quebec Task Force 
Classification of 
WAD II or III  Exclusion: 
WAD IV, experienced 
concussion, LOC or head 
injury, 
previous history of whiplash, 
neck pain/ headaches that 
required treatment. 
Within 1 month Thermal (hot, cold) pain 
thresholds  
 
Brachial plexus provocation test 
(BPPT) 
 
 Sympathetic vasoconstrictor 
reflex 
 
 
GHQ-28 
 
10 cm VAS scale 
Neck disability index 
(NDI)   
 
 
ALL PF’s measured at 
2, 3 
and 6 months post-
injury 
NDI at 6 months 
3 groups – Recovered, Mild, Moderate to Severe Pain and Disability 
at 6 months: PPT’s and TPT’s lower at baseline for “Moderate to 
Severe” group and remained low. Other groups had higher baseline 
thresholds and recovered to normal by 6 months. 
Psychological distress not found to be a predictor of altered central 
pain modulation. No CI’s & OR’s 
Harkness	et	al.	
2004	
Prospective 
cohort 
WP Newly employed workers 
 
Subjects free of WP selected 
for F/u. 
premorbid Detailed questionnaire information 
on: 
Mechanical exposure 
Posture 
Physical environment 
PsychoSoc risk factors 
 
Pain status questionnaire 
based on ACR 1990 
criteria 
12 and 24 months Those who pulled heavy weights had an 80% increased, but not 
statistically significant, risk of symptom onset compared with those 
who did not perform these activities. Those who squatted for >15 
minutes (OR 2.0 95%CI: 1.1-3.6)and those who thought their work 
was monotonous or boring (OR 1.9 95% CI: 1.1–3.2) had a 
significantly increased approximately double) odds of developing 
new-onset WP in 2 years. 
 
Diatchenko	et	
al.	2005	
3 year 
prospective 
longitudinal  
TMD TMD free at baseline, no 
exclusion criteria 
Pre-morbid 
 
COMT genotyping for pain 
sensitivity 
PPT’s 
Ischaemic pain thresholds 
TMD with QST high 
sensitivity 
3 monthly interviews 
and annual physical 
examinations for up to 
3 years to identify new 
onset TMD 
From n=170, n=15 new onset TMD were detected; in whom COMT 
genotypes for HPS were significantly more prevalent than the APS 
and LPS haplotypes. 
HPS haplotypes (and associated pain sensitivity in QST) predict 
new onset TMD. The incidence density ratio of 2.3 was significant 
(95% CI: 1.1–4.8), suggesting that the HPS and/or APS 
haplotypes represent significant risk factors for TMD onset. 
 
Wynne-	Jones	
et	al.	2006	
Prospective 
longitudinal 
WP Inclusion: UK residents, 
fluent in English. 
 
Excluded if reported WP in 
the period 1 month pre-MVA. 
Median 23 days 
post MVA 
General Health Q’aire 
Illness Attitude Q’aire 
Rate general health (excellent to 
poor) 
Somatic Symptom check list 
WP (ACR 1990 criteria) 12 months 54 (7.8%) reported new WP. Few collision-specific factors predicted 
the onset of WP. In contrast, post-collision physical symptoms (rate 
ratio 2.5, 95% confidence interval 1.2–5.1), pre-collision health-
seeking behavior (RR 3.6, 95% CI 1.6–7.9), pre-collision 
somatization (RR 1.7, 95% CI 0.99–2.8), and perceived initial injury 
 Primary care visit count in 1 year 
period pre MVA 
Collision specific factor Q’aire 
Symptom severity Q’aire 
VAS pain scale 
 
severity (RR 1.7, 95% CI 0.9–3.3), in addition to older age (RR 3.3, 
95% CI 1.5–7.1), were all independently predictive of new onset 
WP. In combination, these factors accounted for about a 20-fold 
difference in the risk of new onset WP. 
 
Gupta	et	al.		
2007	
Prospective 
longitudinal 
WP Included if free of WP but 
who showed 
evidence of somatising 
behaviour. 
Pre-morbid Somatic symptom score  
Illness behaviour score  
Total pain threshold  
Tender point count (ACR 1990 
criteria) 
WP (ACR 1990 criteria) 15 months In people who show somatising behaviour a high pre-morbid tender 
point count is associated with the onset of new WP (OR	4.1,	95%	
CI:	1.1	-15.5,	p=0.042), a low pain threshold at baseline is not. 
Ferrari	2010	
	
Prospective 
Longitudinal 
with 
consecutive 
recruitment 
Whiplash 
neck injury 
following 
motor 
vehicle 
accident 
Included: WAD Gd 1 or 2,   
they were seated within the 
interior of a car, 
truck, sports/utility vehicle, or 
van in a collision 
(any of rear, frontal or side 
impact) 
No LOC 
Age 18+ 
Within 7 days accident 
 
Excluded: #’s,neuro signs, 
(i.e. WAD gd 3 – 4) prev 
WAD, non trauma pain 
Non MVA 
 
Within 7 days of 
onset 
Recovery expectation 
questionnaire 
 
Age 
Gender 
 
Initial Whiplash Disability 
Questionnaire score 
BPPT (1- angle of elbow 
flexion  & 2-  10cm VAS) 
3 months Those who expect ‘never to get better’ or ‘don’t know’ have a much 
higher likelihood of developing at least one sign of central 
sensitisation 3 months later. 
Slade	et	al.	
2014	
Nested Case 
control study 
using 
longitudinal 
data from 
prospective 
cohort study. 
TMD Included: English language 
fluency, intention to live in 
the area > 2 years. <5 HA’s 
pcm for previous 3 months, 
no prior TMD symptoms  
/ treatment, absence of 13 
specific health conditions. 
Excluded: orofacial pain >5 
days in past 30 days and/or 
evoked pain in >=3 muscle 
locations or =>1 TMJ. 
 
Pre-morbid PPT’s 
 
Interval between visits 
Study site 
Gender 
Race 
ethnicity  
TMD and PPT’s Up to 5 years Pre-morbid PPT’s measurements not useful in predicting the course 
of TMD (whether TMD will be transient vs persistent) but do provide 
insight into the mechanisms of altered central pain modulation in 
generalized pain in recent onset TMD. 
Markkula	et	al.	
2016	
Prospective 
longitudinal  
WP Included if no pain nor 
exclusion criteria reported in 
1975 and 1981. 
 
Excluded if had rheumatic 
diseases, malignancies, 
Subjects with: missing data 
on regional pain in 1975 & 
1981;WP & likely FM in 1975 
& 1981; reported frequent 
use of analgaesialtered 
central pain modulation in 
1975 or 1981. 
Pre-morbid 
In 1975 
FM Q’aire, medical record data. 
Questions based on other 
predictive study results on:  
Regional pain 
Headaches 
Migraine 
Zygosity (by validated twin q’aire.) 
Sleep 
Weight 
BMI 
Smoking 
Physical activity 
leisure-time activity. 
 
WP or FM using ACR 
1990 criteria for FM 
6 and 15 years:  
T1: 1981, 
T2: 1990. 
The strongest non-genetic predictor was frequent headache (OR 
8.6, CI 95 % 3.8–19.2), followed by persistent back pain (OR 4.7, CI 
95 % 3.3–6.7) and persistent neck pain (OR 3.3, CI 95 % 1.8–6.0). 
Table Glossary: ACR – American College of Rheumatology; WP – widespread pain; FM – fibromyalgia; Q’aire - questionnaire; WAD – whiplash associated disorders; LOC – loss of consciousness; BPPT – brachial plexus 
provocation test; GHQ – general health questionnaire; QST –quantitative sensory testing; PPT – pressure pain threshold; TPT - temperature pain threshold. COMT- catecholamine-O-methyltransferase
 Study Characteristics 
All the studies were prospective longitudinal cohort studies (table 5). All investigated 
prognostic factors with an outcome measure related to altered central pain modulation.  
 
Baseline measurements of predictors were taken pre-morbidly by the majority of studies 
(McBeth et al., 2001; Harkness et al., 2004; Diatchenko et al., 2005; Gupta et al., 2007; 
Slade et al., 2014 and Markkula et al., 2016) and at the acute stage of the pain in Sterling et 
al., (2003), Wynne-Jones et al., (2006) and Ferrari, (2010), so that it was likely that baseline 
predictors were measured before the onset of altered central pain modulation. Follow-up 
measurements were all taken at time points beyond the normal healing time frame, ranging 
from 3 months (Diatchenko et al., 2005; Ferrari, 2010) to 6 months (Sterling et al., 2003), 12 
months (McBeth et al., 2001; Wynne-Jones et al., 2006), 15 months (Gupta et al., 2007), 24 
months (Harkness et al., 2004), 5 years (Slade et al., 2014) and 15 years (Markkula et al., 
2016).  
 
Predictors varied widely across studies and can be grouped according to sensory sensitivity, 
psychological and other factors. Six studies (McBeth et al., 2001; Sterling et al., 2003; 
Diatchenko et al, 2005; Gupta et al., 2007; Slade et al., 2014; Markkula et al., 2016) used 
sensory sensitivity at baseline as a predictive factor of altered central pain modulation. 
Diatchenko et al., (2005) specifically used a genetic marker for sensitivity, unlike the others 
which included quantitative sensory testing (QST) or the American College of Rheumatology 
(ACR; 1990) criteria as predictors. Psychological measures included Somatising Symptoms 
Checklist (McBeth et al., 2001; Gupta et al., 2007) and Illness Attitudes Scale (McBeth et al., 
2001; Wynn-Jones et al., 2006), Illness Behaviour Score (Gupta et al., 2007), Recovery 
Expectation Questionnaire (Ferrari, 2010), perception of premorbid general health including 
psychological distress, using the General Health Questionnaire (McBeth et al., 2001; Sterling 
et al., 2003; Wynne-Jones et al., 2006) and work-related psychosocial risk factors (Harkness 
et al., 2004). Work related physical factors (Harkness et al., 2004) and collision-specific 
factors (Wynne-Jones et al., 2006) were also tested as predictors. 
 
Risk of Bias Assessment 
All studies were ultimately judged as low risk of bias. Diatchenko et al., (2005) initially 
presented as high ROB. It was written in a style relevant to its background of genetics and 
according to the journal requirements in which it was published and in order to review it 
fairly, the supporting information was obtained from the journal website. 
 
 
Table 3. Risk of Bias summary for methodological quality. 
	 Study	participation	
(QUIPS)	
	
	
Target	
Population	
(CHARMS)	
	
Study	
attrition	
/complete	
follow	up	
(QUIPS)	
Prognostic	
Factor	Measure	
(QUIPS)	
Outcome	
measurement	
(QUIPS)	
Study	
confounding	
(QUIPS)	
Statistical	
analysis	
and	
reporting	
(QUIPS)	
Overall	
Statement	of	
Risk	of	Bias	
	
	
	
	
Study	
Data	related	
to	outcome	
may	be	
different	for	
participants	
and	eligible	
non-
participants		
Description	
of	source	of	
participants	
and	inclusion	
and	exclusion	
criteria.	
	
	
Data	related	
to	outcome	
may	be	
different	for	
completing	
and	
non-
completing	
participants	
The	
measurement	
of	the	PF	may	
be	different	for	
different	levels	
of	the	outcome	
of	
interest	
Measurement	
of	the	
outcome	may	
be	different	
related	to	the	
baseline	
level	
Outcome	
may	be	
distorted	by	
another	
factor	
related	to	
outcome	
Reported	
results	
may	be	
spurious	or	
biased	
related	to	
analysis	or	
reporting	
Based	on	
number	of	
low,	
moderate	
and	high	
ratings	
McBeth	et	al.,	
2001	
L	 L	 L	 L	 L	 L	 L	 Low	
Sterling	et	al.,	
2003	
H	 L	 L	 L	 L	 M	 L	 Low	
Harkness	et	al.,	
2004	
L	 L	 H	 L	 L	 L	 L	 Low	
Diatchenko	et	al.,	
2005	
L	 L	 H	 L	 L	 L	 L	 Low	
Wynne-	Jones	et	
al.,	2006	
L	 L	 H	 L	 L	 L	 L	 Low	
Gupta	et	al.,		2007	 L	 L	 L	 L	 L	 L	 L	 Low	
Ferrari,	2010	 L	 L	 L	 L	 H	 L	 M	 Low	
Slade	et	al.,	2014	 M	 L	 H	 L	 M	 L	 L	 Low	
Markkula	et	al.,	
2016	
L	 L	 L	 L	 L	 L	 L	 Low	
L=	low	risk	of	bias;	M	=	moderate	risk	of	bias;	H	=	High	risk	of	bias.	
QUIPS	=	Quality	in	Prognostic	Studies	
CHARMS	=	Checklist	for	Critical	Appraisal	and	Data	Extraction	for	Systematic	Reviews	of	Prediction	
Modelling	Studies	
	
 
 
Three main groups of predictors were identified across the studies as: 1) sensory sensitivity 
factors, 2) psychological factors, and 3) other factors (Table 6). According to the groups, there 
might be a higher risk of the patient developing altered central pain modulation, if: 
1) High sensory sensitivity can be identified at baseline using QST or the ACR guidelines 
for tender point counts or genetic testing for sensory sensitivity; 	
2) Somatisation, poor illness attitudes and negative expectation of recovery can be 
identified at baseline, (Somatisation Checklist; Illness Attitudes questionnaire; 
Expectation of Recovery questionnaire);	
3) Pre-morbid frequent headaches were apparent.	
 
 
Table 6: Clinical interpretation of results 
Author Grouped Results Quality of 
evidence and 
strength of 
recommendation 
(GRADE score) 
 
Sensory Hypersensitivity at baseline 
 
Sterling et al., 
(2003) 
Higher sensory sensitivity (using QST) within 4 weeks of 
a whiplash injury is a predictor of altered central pain 
modulation (low PPT) at 6 months, associated with 
moderate to severe pain and disability and poor 
recovery.  
 
High sensory sensitivity at the acute stage is apparent in 
all individuals who experienced a whiplash injury but 
sensory sensitivity is 1) less elevated at baseline and 2) 
returns to normal, in those who do not develop altered 
central pain modulation at 6 months, compared with 
those who do.  
 
Moderate  
Diatchenko et 
al., (2005) 
Genetic sensitivity to pain, associated with pre-morbid 
pain sensitivity to QST is a predictor of altered central 
pain modulation (TMD with low PPT’s and ischaemic 
pain thresholds). 
In this study group, healthy individuals with genetic 
markers for sensitivity (COMT genotyping for HPS 
haplotypes) developed TMD with altered central pain 
modulation.  
 
Gupta et al.,  
(2007) 
A high pre-morbid tender point count is a predictor of 
altered central pain modulation (WP). In healthy pain-free 
individuals who show somatising behaviour 
(Somatisation Check list), PPT’s taken at all 16 points 
are summed to make a total PPT score. Of those PPT’s, 
the ones measuring <4kg/cm² are counted as tender 
points and totalled up per participant. 
 
Slade et al., 
(2014) 
After the onset of TMD, pre-morbid low PPT’s are a 
predictor of persistent pain and altered central pain 
modulation (low PPT). 
 
 
Psychological factors 
 
McBeth et al., 
(2001) 
In a healthy population, those who show evidence of 
somatisation before pain onset are more likely to 
experience altered central pain modulation in the form of 
WP within 12 months of showing somatisation.  
 
 
 
 
Moderate 
 
 
 
 
Wynne- Jones 
et al., (2006) 
A tendency towards somatisation and health seeking 
behaviour pre-morbidly (Somatisation check list and 
GHQ), increased perception of initial injury severity 
(Illness attitudes questionnaire) severity of initial 
symptoms (symptom severity questionnaire) and older 
age all predict altered central pain modulation (WP) after 
a whiplash injury. 
 
Ferrari, (2010) 
 
Responses of [I expect] ‘never to get better’ or ‘don’t 
know’ on the Recovery Expectation questionnaire are 
predictors of altered central pain modulation (BPPT with 
VAS) after whiplash by 3 months. 
 
 
Other factors 
 
Markkula et 
al., (2016) 
In a healthy population, pre-morbid frequent headache, 
followed by subsequent persistent regional back or neck 
pain are predictors of altered central pain modulation 
(WP). 
NA 
NA= not applicable 
 
None of the studies selected were specific to low back pain, therefore predictors of altered 
central pain modulation in low back pain could not be determined. 
 
 
 Discussion  
This study set out to 1) identify predictors of altered central pain modulation in adults with 
general musculoskeletal pain conditions and secondly, if data were to allow, 2) determine 
predictors for NSLBP. We found nine high quality articles, and identified three groups of 
predictors of altered central pain modulation, two with a moderate strength of evidence 1) 
sensory sensitivity factors, 2) psychological factors and one which only included one study 3) 
other factors.  
 
Some overlapping themes were found, for example, across all studies the musculoskeletal 
pain conditions were limited to whiplash, temporomandibular disorder (TMD) and 
widespread pain (WP). Similarly, sensory sensitivity tests were limited to QST, the ACR 
guidelines (1990) and COMT (catecholamine-O-methyltransferase) genetic testing. There 
was more variation across psychological measures, although the Somatisation Checklist and 
GHQ were used three times, enabling some qualitative comparisons. In this review, we did 
not find any articles that had studied the predictors of altered central pain modulation in 
NSLBP. 
 
Due to the relatively new concept of altered central pain modulation in the last 15 years there 
has been little consensus as to what predictors lead to altered central pain modulation. It is 
therefore perhaps not surprising that many of the predictors tested varied widely as 
researchers attempt to narrow down the possibilities. The heterogeneity of predictors and of 
outcome measures made grouping of factors and outcomes for comparisons broad and 
prevented meta-analysis of the results. 
Definitions of altered central pain modulation 
One challenge during this review was a lack of definition for altered central pain modulation. 
At the time of publication of many of the studies, there was a lack of clinical guidelines on 
how to identify altered central pain modulation in patients. Altered central pain modulation 
was not directly defined but could be inferred. Some of the studies used the ACR guidelines 
(1990) as a validated measure of WP (McBeth et al., 2001; Harkness et al., 2004; Wynn-
Jones et al., 2006; Gupta et al., 2007; Markkula et al., 2016). Although the full ACR 
guidelines provide diagnostic criteria for identifying fibromyalgia, a section of the guidelines 
specifically identify WP. WP is indicative of altered central pain modulation (Nijs et al., 2014) 
and is an appropriate primary outcome measure for altered central pain modulation to be 
included in the current review. 
The musculoskeletal pain disorders studied also allowed for inference of altered central pain 
modulation: Whiplash grade 1 or 2 (Sterling et al., 2003; Ferrari, 2010), WP (McBeth et al., 
2001; Harkness et al., 2004; Wynn-Jones et al., 2006; Gupta et al., 2007; Markkula et al., 
2016) and TMD (Diatchenko et al, 2005; Slade et al., 2014). These musculoskeletal pain 
disorders, when chronic, have been described as being closely associated with altered 
central pain modulation (Yunus, 2008; Kindler et al., 2010, Mayer et al., 2012) increasing the 
likelihood that the study populations in the current review contain a proportion presenting 
with altered central pain modulation at follow-up.  
Quantitative Sensory Testing (QST) was used in four studies and included PPT (Sterling et 
al., 2003; Diatchenko et al., 2005; Ferrari, 2010; Slade et al, 2014); Temperature Pain 
Thresholds (TPT; Sterling et al., 2003) and the Brachial Plexus Provocation Test (BPPT; 
Sterling et al.,2003; Ferrari, 2010). Whilst PPT’s are a valid measure of altered central pain 
modulation (Shy et al., 2003), BPPT, although associated, has not been validated 
specifically for measuring altered central pain modulation in Ferrari (2010). Despite this, the 
BPPT has been accepted for use by some authors as a test to indicate central 
hypersensitivity in whiplash associated disorders (Sterling, 2008), enabling these two studies 
Sterling et al., (2003) and Ferrari, (2010) to be eligible for inclusion into the current review.  
 
Should baseline measures be taken pre-morbidly or during the acute stage?  
In the current study, it was assumed a priori that taking baseline measurements in the acute 
stage of injury precedes the onset of altered central pain modulation. Sterling et al., (2003) 
argue that acute stage measures may not accurately reflect pre-morbid sensory sensitivity 
as alterations in central pain modulation may have already taken place. However, it could be 
argued acute-stage sensitivity measures do give an indication of pre-morbid sensitivity 
status, as in the study by Sterling et al., (2003), those who developed altered central pain 
modulation showed higher sensitivity at baseline than the rest of the acute-stage cohort, and 
remained higher at follow-up. 
 
Pre-morbid baseline measures were taken in the population based studies reported in the 
current review, with the advantage that the predictors were clearly taken prior to the 
development of altered central pain modulation symptoms. As well as the disadvantage of 
longer periods needed to reach post-morbid follow-up, longer time frames may introduce 
confounders based on demographic and time-dependent co-morbidities. Wynne-Jones et al., 
(2006), possibly attempted to overcome this by measuring baseline pre-morbid predictors 
retrospectively using questionnaires around the time of the whiplash (acute stage). While 
this is commendable, a drawback might have been participant recall bias. 
 
Negative results 
Gupta et al., (2007) and Slade et al., (2014) both found pre-morbid PPT’s not to be 
predictive of new onset altered central pain modulation-related musculoskeletal pain. The 
study by Gupta et al., (2007), was underpowered and did not find a significant change from 
baseline PPT’s in order to predict first onset WP within 15 months. This may also have been 
related to the group being an already–at–risk group, with somatization as an inclusion 
criteria. These participants may have already had lower PPT’s than a healthy population, 
making differences more difficult to detect. 
 
Although Slade et al., (2014) specifically sought to find predictors of new onset TMD with 
altered central pain modulation, their results did show that at follow-up, participants with a 
lower baseline PPT tended to sensitise more vigorously, developing TMD with even lower 
PPT’s post-morbidly. Those with PPT’s closer to normal pre-morbidly and who experienced 
TMD did not develop persistent symptoms and altered central pain modulation but instead 
made a full recovery. Therefore, it may be interpreted that individuals with pre-morbid low 
PPT’s may be at greater risk of developing persistent pain with altered central pain 
modulation, in a TMD population. This may be generalizable to other altered central pain 
modulation populations such as whiplash, based on Sterling et al., (2003). Sterling et al. 
measured baseline PPT’s within the acute stage of whiplash injury and found that those with 
lower baseline PPT’s developed persistent pain with altered central pain modulation by 6 
months. 
 
There may be a difference between insidious onsets of WP or TMD versus traumatic onset 
of pain following a motor vehicle accident (MVA). Unfortunately, the three studies (Sterling et 
al., 2003; Ferrari, 2010; Wynne-Jones et al., 2006), where the baseline was during the acute 
stage following a MVA, used different predictors of altered central pain modulation onset and 
therefore cannot be grouped to compare with studies including insidious pain onset.  
 
Future considerations 
Although sensory hyper-sensitivity has been measured as a predictor, other aspects of 
sensory processing alterations have not been evaluated, such as sensory hypo-sensitivity. 
Mailis-Gagnon and Nicholson (2010) have found sensory hypo-sensitivity to be a feature of a 
sub-group of fibromyalgia patients and these have not been used as predictors in prognostic 
studies to date. Measures of QST do not provide a full reflection of sensory alterations or 
differences because they only measure sensory hyper-sensitivity to particular stimuli.  
 
Genetic markers for sensory sensitivity were discussed in two papers – Markkula et al., 
(2016) with regard to twins and Diatchenko et al., (2005) with regard to COMT haplotypes. 
Both studies discuss the likelihood of genetic predisposition to altered central pain 
modulation, either insidiously or after the first onset of musculoskeletal pain. It may be 
proposed, on the basis of the current findings, that pre-morbid trait sensory sensitivity and 
psychological characteristics such as coping styles, possibly of partly genetic origin, may 
predispose to altered central pain modulation, either insidiously or once regional pain is 
experienced. 
 
 
Psychological predisposition 
Ferrari (2010) used a one-question questionnaire as a predictor in which expectation of 
recovery predicted altered central pain modulation in a whiplash group. This is a 
psychological variable and no baseline physical examination was performed to assess for 
altered central pain modulation for longitudinal comparison. Three studies (Gupta et al., 
2007, Wynne-Jones et al., 2006 and McBeth et al., 2004) found that a tendency towards 
somatisation pre-morbidly was a predictor of altered central pain modulation. Somatisation is 
said to be a measure of distress and anxiety, manifesting as physical symptoms (Kroenke et 
al., 1998). Pre-morbid anxiety was not assessed in any of the studies; it may be useful to 
assess for pre-morbid trait anxiety characteristics in future studies. Distress is a measure of 
coping styles, none of which were assessed as predictors in any of the studies in the current 
review. Trait anxiety and coping styles may be an important element in the aetiology of 
altered central pain modulation based on somatisation being a predictor in the current 
review. 
 
Predisposition requires a trigger before altered central pain modulation develops 
It is suggested that if a person is predisposed to altered central pain modulation, there 
requires a trigger, such as an injury or trauma, to start the transition to altered central pain 
modulation (Diatchenko et al., 2007; Markkula et al., 2016). This echoes the observations by 
Latremolier and Woolf (2009) that it is not known why some people tend to sensitise more 
vigorously after an injury. Markkula et al., (2016) found that if there was initially some 
regional pain (back or neck) or headaches, this predicted the transition to altered central 
pain modulation in the form of WP. What is unknown from Markkula et al., (2016) is whether 
the regional pain was predominantly nociceptive, which might be an important distinction to 
make in predicting altered central pain modulation. 
 
	
Methodological Strengths 
The strengths of this review are based around the methodological rigour and the use of 
altered central pain modulation-specific inclusion / exclusion criteria. Two independent 
reviewers carried out the searches and a third reviewer was available for discussion. Search 
terms were piloted on advice from previous authors on searching for prognostic or predictive 
studies.  
 
Methodological guidelines were followed according to more than one source (David et al., 
2009, Dretzke et al., 2014 and Moons et al., 2014). The search strategy included relevant 
databases without filter limitations, extensive hand searching and the contacting of a large 
number of pain researchers in order to include any potential studies. A priori registration of 
the review was done.  
Valid risk of bias and data extraction tools were used (Hayden et al., 2013; Moons et al., 
2014) and strict inclusion / exclusion criteria were developed from current guidelines and 
literature specific to altered central pain modulation enabling close adherence to the 
research question. 
 
Methodological Limitations 
Only papers published in English were included, to the exclusion of two in German. One 
paper could not be retrieved. Altered central pain modulation had to be inferred due to the 
lack of definitions available at the times of publication. Interpretation of the reporting of each 
study where altered central pain modulation was only inferred presented as a challenge at 
review level. This careful interpretation was done in order to extract altered central pain 
modulation-specific information and, despite adhering closely to current altered central pain 
modulation guidelines, may present as a limitation.  
 
Conclusion 
Nine studies were included in the review to identify predictors of altered central pain 
modulation in adults with general musculoskeletal pain conditions. We found moderate 
strength of evidence to suggest that sensory hypersensitivity and somatisation pre-morbidly, 
or higher sensory sensitivity and low expectation of recovery at the acute stage of pain are 
predictors of altered central pain modulation in some musculoskeletal pain conditions. The 
implications for this review are that pre-morbid traits of sensory sensitivity and anxiety 
(somatisation) might play a role in the development of altered central pain modulation. 
Further investigations into pre-morbid characteristics of individuals with altered central pain 
modulation is warranted. This may help identify risk factors likely to predispose a person with 
acute musculoskeletal pain to the development of chronic pain with altered central pain 
modulation. 
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